ADMINISTER NERVE AGENT ANTIDOTE KIT (MARK I) TO SELF
a. Identify. The Mark I nerve agent antidote kit (NAAK) (figure 2-1) consists of
four separate components: the atropine autoinjector, the pralidoxime chloride
autoinjector, the plastic clip, and the foam envelop (carrying case).
Figure 2-1. Nerve agent antidote kit, Mark I.
(1) The atropine autoinjector consists of a hard plastic tube that has 2 mg
(0.7 ml) of atropine. Its pressure activated coiled spring triggers the needle for injection.
The plastic container is white. It has green identification and direction labels with white
lettering. It has a yellow plastic safety cap attached at the rear of the container. At the
needle end is a green plastic cap. When pressure is applied, the spring mechanism is
(2) The 2-PAM Cl autoinjector is a hard plastic tube that dispenses 600
mg/2 ml of 2-PAM Cl (300 mg/ml) solution when activated. The pressure activated coil
spring is identical to that of the atropine autoinjector. This container is clear plastic. It
has a light brown identification label with black lettering. The directions are in black
letters on a white background. The gray plastic safety cap is attached to the clip at the
rear of the container. The needle end is black plastic.
(3) The clip is clear hard plastic. It is constructed to hold the pair of
autoinjectors together while attached to their safety caps.
(4) The foam envelope is a charcoal gray foam fitting case with pressed
seams. It is designed to carry both autoinjectors, and is used for shipping purposes
only. Remove the envelope prior to putting the injectors in your mask carrier.
b. Administer. If you are having signs and symptoms of nerve agent poisoning,
STOP BREATHING AT ONCE, AND DO NOT INHALE UNTIL YOU HAVE MASKED.
After you have masked, and if you have signs and symptoms of nerve agent poisoning,
follow the steps for administering the nerve agent antidote.